BR112014009225A2 - uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes - Google Patents

uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes

Info

Publication number
BR112014009225A2
BR112014009225A2 BR112014009225A BR112014009225A BR112014009225A2 BR 112014009225 A2 BR112014009225 A2 BR 112014009225A2 BR 112014009225 A BR112014009225 A BR 112014009225A BR 112014009225 A BR112014009225 A BR 112014009225A BR 112014009225 A2 BR112014009225 A2 BR 112014009225A2
Authority
BR
Brazil
Prior art keywords
whey protein
protein micelles
young children
obesity
diabetes
Prior art date
Application number
BR112014009225A
Other languages
English (en)
Other versions
BR112014009225A8 (pt
Inventor
Mace Catherine
Pouteau Etienne
Jean René Bovetto Lionel
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47045036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014009225(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR112014009225A2 publication Critical patent/BR112014009225A2/pt
Publication of BR112014009225A8 publication Critical patent/BR112014009225A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00—Whey; Whey preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

resumo patente de invenção: "uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes". a presente invenção refere-se às micelas de proteína de soro de leite para utilização no tratamento e/ou na prevenção de uma doença associada a um aumento na secreção de insulina e/ou concentração de igf- 1 no plasma em um criança pequena em risco de desenvolvimento de obesidade ou diabetes. a presente invenção também refere-se a uma composição nutricional para crianças pequenas compreendendo as micelas de proteína de soro de leite. além disso, a presente invenção refere-se a uma utilização não terapêutica de uma composição nutricional para crianças pequenas, compreendendo as micelas de proteína de soro de leite.
BR112014009225A 2011-10-21 2012-10-19 uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes BR112014009225A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11186141.5A EP2583562A1 (en) 2011-10-21 2011-10-21 Use of whey protein micelles for infants at risk of obesity or diabetes
PCT/EP2012/070718 WO2013057233A1 (en) 2011-10-21 2012-10-19 Use of whey protein micelles for infants at risk of obesity or diabetes

Publications (2)

Publication Number Publication Date
BR112014009225A2 true BR112014009225A2 (pt) 2017-06-13
BR112014009225A8 BR112014009225A8 (pt) 2017-06-20

Family

ID=47045036

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014009225A BR112014009225A8 (pt) 2011-10-21 2012-10-19 uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes

Country Status (10)

Country Link
US (1) US10028978B2 (pt)
EP (2) EP2583562A1 (pt)
CN (1) CN103906440B (pt)
AU (1) AU2012324887B2 (pt)
BR (1) BR112014009225A8 (pt)
CL (1) CL2014000865A1 (pt)
ES (1) ES2643892T3 (pt)
MX (1) MX350866B (pt)
RU (1) RU2616525C2 (pt)
WO (1) WO2013057233A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
WO2015065193A1 (en) * 2013-11-01 2015-05-07 N.V. Nutricia Lipid composition for improving body composition during catch-up growth
CN105764355A (zh) * 2013-11-25 2016-07-13 雀巢产品技术援助有限公司 乳基营养组合物与胃部不适
EP3082463B1 (en) * 2013-11-29 2019-05-01 Nestec S.A. Use of nutritional compositions having a low protein amount
WO2015078974A1 (en) * 2013-11-29 2015-06-04 Nestec S.A. Infant nutrition for improvement in insulin sensitivity later in life
WO2015085555A1 (en) * 2013-12-12 2015-06-18 Nestec S.A. Array of age-tailored infant formula with optimum protein content and lactose content
DK3361885T3 (da) 2015-10-15 2019-07-29 Nutricia Nv Modermælkserstatning med særlig lipidarkitektur til fremme af sund vækst
WO2018104512A1 (en) 2016-12-09 2018-06-14 N.V. Nutricia Nutritional composition for improving cell membranes
EP3568028B1 (en) 2017-01-11 2022-11-16 Société des Produits Nestlé S.A. Use of whey protein micelles and a source of casein for liquid spoonable nutritional compositions
CN110381964A (zh) * 2017-03-03 2019-10-25 森永乳业株式会社 Glp-1分泌促进剂和组合物
US20220233597A1 (en) * 2019-06-13 2022-07-28 Societe Des Produits Nestle S.A. Use of whey protein micelles for controlling postprandial glucose response
EP4054604A1 (en) * 2019-11-08 2022-09-14 Abbott Laboratories Bovine milk-isolated powdered exosomes, nutritional compositions and methods

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2683492B2 (ja) * 1993-09-07 1997-11-26 雪印乳業株式会社 ミセル状ホエー蛋白質、その溶液、その粉末およびミセル状ホエー蛋白質の製造法
US6303586B1 (en) * 1997-08-29 2001-10-16 The Ricex Company Supportive therapy for diabetes, hyperglycemia and hypoglycemia
ATE228779T1 (de) * 1999-01-20 2002-12-15 Nutricia Nv Säuglingsnährpräparat
DE19964370B4 (de) * 1999-02-16 2006-05-11 Huss, Manfred Herstellung eines geschäumten Molkenproteinprodukts
GB0302929D0 (en) * 2003-02-10 2003-03-12 Inst Of Child Health Nutrient composition
DE602004014275D1 (de) * 2003-06-30 2008-07-17 Nestec Sa Zusammensetzung zur behandlung und/oder vorbeugung von insulinresistenz
JP2007525404A (ja) * 2003-08-30 2007-09-06 ネステク ソシエテ アノニム ミセルカゼインの酸可溶性蛋白質
MY153295A (en) * 2004-09-29 2015-01-29 Nestec Sa Nanoparticulated whey proteins
RU2390269C2 (ru) 2004-12-27 2010-05-27 Нестек С.А. Применение молочной смеси для детского питания с пониженным содержанием белка
WO2007004878A2 (en) 2005-07-01 2007-01-11 N.V. Nutricia Infant nutrition with hydrolised proteins
PL1962823T3 (pl) 2005-12-23 2015-08-31 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka i mangan i/lub molibden do poprawy składu błony komórkowej
ES2373400T3 (es) 2006-03-27 2012-02-03 Nestec S.A. Micelas de proteína láctea.
ES2348963T3 (es) * 2006-03-27 2010-12-17 Nestec S.A. Utilizacion cosmetica de micelas de proteinas de suero.
EP1932437A1 (en) 2006-12-15 2008-06-18 Nestec S.A. Infant formula
CN101438738A (zh) * 2007-11-23 2009-05-27 内蒙古蒙牛乳业（集团）股份有限公司 一种降血糖的酸奶及其生产方法
WO2010043415A2 (en) 2008-10-17 2010-04-22 Nestec S.A. Ashby, Kevin Whey protein compositions, methods and uses
SG2014011142A (en) * 2010-03-12 2014-05-29 Nestec Sa Compositions for masking the flavor of nutrients and methods for making same

Also Published As

Publication number Publication date
AU2012324887B2 (en) 2015-10-29
ES2643892T3 (es) 2017-11-27
MX2014004802A (es) 2015-12-03
US20140287056A1 (en) 2014-09-25
CN103906440B (zh) 2016-09-21
BR112014009225A8 (pt) 2017-06-20
WO2013057233A1 (en) 2013-04-25
EP2779846B1 (en) 2017-09-06
CN103906440A (zh) 2014-07-02
RU2014120428A (ru) 2015-11-27
AU2012324887A1 (en) 2014-04-03
CL2014000865A1 (es) 2014-08-18
MX350866B (es) 2017-09-22
EP2583562A1 (en) 2013-04-24
RU2616525C2 (ru) 2017-04-17
US10028978B2 (en) 2018-07-24
EP2779846A1 (en) 2014-09-24

Similar Documents

Publication Publication Date Title
BR112014009225A8 (pt) uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes
IN2014KN02830A (pt)
PH12016500959A1 (en) Use of nutritional compositions having a low protein amount
TN2015000283A1 (fr) Functionalized exendin-4 derivatives
BR112014010275A2 (pt) formulações para tratamento de diabetes
MY196432A (en) Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health
MX2013009948A (es) Composiciones de insulina y cromo para el tratamiento y prevencion de diabetes, hipoglucemia y alteraciones relacionadas.
EA201591529A1 (ru) Лечение детского дефицита гормона роста человеческими аналогами гормона роста
BR112013029269A8 (pt) combinação farmacêutica para uso na indução de perda de peso em pacientes com diabetes tipo 2 e/ou para prevenir o ganho de peso em pacientes com diabetes tipo 2
BR112013029256A8 (pt) combinação farmacêutica para uso no tratamento de pacientes com diabetes tipo 2
BR112013029062A2 (pt) lixisenatida e metformina para o tratamento de diabetes tipo 2
RU2015122497A (ru) Содержащие лактоферрин питательные композиции на основе молока и их применение
MY175195A (en) Nutritional compositions
BR112015011931A2 (pt) composições nutricionais contendo treonato de magnésio e usos das mesmas
BR112014012460A2 (pt) proteínas recombinantes e seus usos terapêuticos
UA117480C2 (uk) Лікування цукрового діабету за допомогою складу інсуліну тривалої дії
BR112015006656A8 (pt) composições e métodos para o tratamento de insuficiência cardíaca em pacientes diabéticos
BR112014001472A2 (pt) galactooligossacarídeos para prevenir lesões e / ou promover a cicatrização do trato gastrointestinal
EA201491369A1 (ru) Способ лечения сахарного диабета при помощи негликозилированного аполипопротеина a-iv
BR112014000182A2 (pt) mascaramento do amargor
EA201791611A1 (ru) Лечение пациентов детского возраста с сахарным диабетом 2 типа с помощью ликсисенатида
BR112014009414A2 (pt) uso de micelas de proteína de soro do leite para melhorar o perfil de insulina em pacientes diabéti-cos
MX2017003659A (es) Composicion nutricional con bajo contenido de acidos grasos de cadena media en proporciones especificas y sus usos.
PH12015500683A1 (en) Formula fortifier
BR112014019857A8 (pt) Métodos para fabricar bebidas semelhantes ao leite

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 35/20 (2006.01), A23C 21/00 (2006.01), A23L 3

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2484 DE 14-08-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B350 Update of information on the portal [chapter 15.35 patent gazette]